Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1 · 50%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 50%Moderate 0 · 0%High 0 · 0%

Summary of findings ‐ Intranasal lorazepam vs intramuscular paraldehyde

Seizure recurrence within 24 hours · Children with acute tonic‐clonic seizures

Summary of findings ‐ Intranasal lorazepam showed no clear difference in seizure recurrence within 24 hours compared with intramuscular paraldehyde (low certainty).

1 finding from 1 review

Drug management for acute tonic‐clonic convulsions including convulsive status epilepticus in children 2018 · Cochrane Headline outcomes only
RR 0.73 [0.31, 1.71]
1 study · 160 participants
Low

Summary of findings ‐ Intravenous lorazepam vs intranasal lorazepam

Seizure recurrence within 24 hours · Children with acute tonic‐clonic seizures

The review found no eligible studies for this question.

1 finding from 1 review

Drug management for acute tonic‐clonic convulsions including convulsive status epilepticus in children 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found